A Study on the Effects of Combined FMT on Gut Microbiota and Eating Disorder Symptoms in AN
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 30 people, planned
- Started
- 1 Sept 2025
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Fecal Microbiota Transplantation
- Placebo
- Record updated
- 22 October 2026
Who can take part
- Age
- 12 years to 35 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Female, aged 12-35 years, meets DSM-5 diagnostic criteria for anorexia nervosa
- BMI > 14 kg/m²; for children/adolescents, BMI > the 0.3 percentile for their age
- Presence of digestive symptoms (e.g., constipation, bloating, diarrhea)
- Duration of the disease (since the onset of dieting and weight loss) is less than two years
- Each patient must understand the nature of this study and sign an informed consent form
Who cannot take part
- Previous pathological intestinal inflammatory conditions such as inflammatory bowel disease
- Use of medications such as probiotics or antibiotics that clearly affect the intestinal flora within 1 months prior to the visit or during the treatment
- Co-morbid severe mental disorders such as schizophrenia, bipolar disorder, intellectual disability, persistent delusional disorder, schizoaffective disorder, or organic mental disorders
- Those with severe low body mass anorexia nervosa (e.g., blood pressure < 80/50 mmHg, heart rate < 40 beats/min, weight loss > 1 kg per week, or those requiring assistance in sitting or squatting in a prone position)
- Patients with severe somatic diseases or comorbidities, including:
- History of traumatic brain injury, cerebral palsy, encephalitis, or other organic brain disorders
- Severe hepatic or renal insufficiency (defined as levels greater than three times the upper limit of normal)
- Substance abusers/addicts, individuals with a high suicide risk, or those with strong destructive impulses or antisocial behavior
- Organic intestinal lesions such as congenital megacolon, intestinal obstruction, or intussusception
- Pregnant or breastfeeding women
- Any other reason that the investigator deems unsuitable for participation in this clinical trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to determine if Fecal Microbiota Transplantation (FMT) is effective in treating Anorexia Nervosa (AN). The study will also explore how FMT works. The main questions it aims to answer are:
Read full original descriptionShow less
1. What is the efficacy of combined FMT treatment in patients with AN? 2. What is the relationship between treatment efficacy and changes in gut microbiota, and what mechanisms underlie the effects of FMT in treating AN? Researchers will compare FMT to a placebo (a look-alike substance that contains no active ingredients) to see if FMT is effective in treating AN.
Participants will:
* Be hospitalized * Take FMT or placebo daily for 6 days * Provide stool and blood samples before and after FMT * Visit the clinic every 4 weeks for check-ups and tests
The 2 groups in the trial
- Fecal Microbiota TransplantationExisting treatment, for comparison
The FMT capsules used in this study contain processed, frozen stool from healthy donors, providing gut microbiota from these individuals. The FMT capsules meet relevant manufacturing standards. Patients take the capsules twice daily, with a dose of 6 or 10 capsules per day, over a period of 6 days (for a total of 72 or 120 capsules). Select the capsule dosage based on age. For children under 18 years old, take 10 capsules at a time. For adults aged 18 and above, take 6 capsules at a time.
- PlaceboPlacebo, for comparison
The placebo capsules, manufactured by the same company, are identical in appearance, size, color, dosage form, weight, and taste to the FMT capsules. Starch is used as the main ingredient to mimic the FMT capsules.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomsized Controlled Study on the Effects of Combined Fecal Microbiota Transplantation on Gut Microbiota and Eating Disorder Symptoms in Patients With Anorexia Nervosa
- Record updated
- 22 October 2026